Global OTC Pharmaceutical Market Forecast 2019-2029

OTC医薬品の世界市場2019-2029

◆タイトル:Global OTC Pharmaceutical Market Forecast 2019-2029
◆商品コード:VGN910368
◆調査・発行会社:visiongain
◆発行日:2019年7月31日
◆ページ数:212
◆レポート形式:PDF / 英語
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆産業分野:医療
◆販売価格オプション(消費税別)
Sigle UserGBP3,499 ⇒換算¥472,365見積依頼/購入/質問フォーム
Departmental/Five UserGBP3,899 ⇒換算¥526,365見積依頼/購入/質問フォーム
Site LicenseGBP4,999 ⇒換算¥674,865見積依頼/購入/質問フォーム
※Single UserとDept Licence(Five User)の場合、DRM(デジタル著作権管理)付PDFファイルです。認証されたPC上のみでの閲覧と、PDF閲覧期限は購入日より1年となります。Dept Licence(Five User)は印刷できますが、Single Userは印刷できません。Site Licence/Global Site Licenseの場合は、閲覧・印刷制限はありません。
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はvisiongainの日本における正規販売代理店です。

【レポートの概要】

本調査レポートでは、"OTC医薬品の世界市場2019-2029"について調査・分析し、レポートサマリー、世界市場規模・市場予測、地域別市場分析、主要国別市場分析、市場環境分析、主要企業分析、結論などの情報をお届けいたします。

The global OTC Pharmaceuticals market is estimated to be $162.64bn in 2018 and is expected to grow at a CAGR of 6.5% during the forecast period.How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 212-page report you will receive 100 tables and 103 figures- all unavailable elsewhere.
The 212-page report provides clear detailed insight into the Global OTC Pharmaceutical market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand-new report today you stay better informed and ready to act.
Report Scope
• Global OTC Pharmaceutical Market forecasts from 2019-2029
• This report breaks down the revenue forecast of the Global OTC Pharmaceutical by product:
• Analgesics
• Cough, cold and allergy products
• Dermatological products
• Gastrointestinal products
• Eye Care
• Smoking Cessation Aids
• Other products
Each submarket is further broken down by region: North America, South America, Europe, Asia-Pacific and RoW
• This report provides individual revenue forecasts to 2029 for these regional and national markets:
• North America: the US, Canada, Mexico
• South America: Brazil, Argentina, Paraguay, Bolivia, Rest of South America
• Europe: Germany, France, the UK, Spain, Italy, Rest of Europe
• Asia-Pacific: China, Japan, India, Australia, Thailand, Rest of Asia-Pacific
• Rest of the World: Middle East, Africa, Other Countries

Each regional market is further broken down by product.
• Our study provides a SWOT analysis and Porter’s Five Forces analysis of the Global OTC Pharmaceutical market
• This report discusses the leading companies in the Global OTC Pharmaceutical market
• Bayer AG
• Cipla, Inc.
• Daiichi Sankyo Co., Ltd
• GlaxoSmithKline (GSK) Consumer Care
• Johnson & Johnson
• Perrigo Company PLC
• Pfizer Inc.
• Procter & Gamble
• Reckitt Benckiser Group PLC
• Sanofi S.A
• Key Questions Answered by this Report:
• How is the OTC pharmaceuticals market evolving?
• What is driving and restraining the OTC pharmaceuticals market growth?
• What are the market shares of the leading segments within the OTC pharmaceuticals market in 2018?
• How will the leading products in the OTC pharmaceuticals market grow over the forecast period and how much revenue will they account for in 2029?
• Which therapies will be the main drivers of the overall market from 2018 to 2029?
• How will the market shares of the national markets change by 2029 and which geographical region will lead the market in 2029?
• Who are the leading OTC pharmaceuticals companies, and what are their prospects over the forecast period?
• What are the predictions for M&A activity, consolidation for existing players and the potential prospects for new market entrants?
Visiongain’s study is intended for anyone requiring commercial analyses for the Global OTC Pharmaceutical Market. You find data, trends and predictions.
Buy our report today Global OTC Pharmaceutical Market Forecast 2019-2029: Cough, Cold and Allergy, Analgesics, Gastrointestinal, Dermatology, Eye Care, Smoking Cessation Aids, Others.

【レポートの目次】

1. Report Overview
1.1 The OTC Pharmaceuticals Market Overview
1.2 Research Methodology
1.2.1 Secondary Research
1.2.2 Market Evaluation & Forecasting Methodology
1.3 Global OTC Pharmaceutical Market Segmentation
1.4 Why You Should Read This Report
1.5 How this report delivers?
1.6 Key Questions Answered by This Analytical Report
1.7 Frequently Asked Questions (FAQ)
1.8 Who is This Report For?
1.9 Associated Visiongain Reports
1.10 About Visiongain

2. Introduction to OTC Pharmaceuticals
2.1 What Are OTC Pharmaceuticals?
2.2 Classification of OTC Pharmaceuticals
2.3 What are the Requirements for an OTC Pharmaceutical Drug?
2.4 OTC Switching
2.4.1 How Is a Drug Switched from Prescription to OTC?
2.4.2 Manufacturing and Distribution of OTC Pharmaceuticals
2.5 Regulation of OTC Pharmaceuticals
2.5.1 Regulation of OTC Pharmaceuticals in the US
2.5.2 Regulation of OTC Pharmaceuticals in Japan: Deregulating the Sales of OTCs
2.5.3 Regulations of OTC Pharmaceuticals in Europe
2.5.4 Regulation of OTC Pharmaceuticals in China
2.5.5 Regulation of OTC Pharmaceuticals in Other Countries

3. Global OTC Pharmaceutical Market Forecast 2019-2029
3.1 The Current State of the OTC Pharmaceuticals Market

4. Global OTC Pharmaceutical Market by Product: Market Forecast 2019 – 2029
4.1 Overview
4.2 Cough, Cold and Allergy
4.2.1 Anti-Allergy Products
4.2.2 Market size and forecast 2019-2029
4.3 Analgesics
4.3.1 Internal Analgesics
4.3.2 External Analgesics
4.3.3 Market size and forecast 2019-2029
4.4 Gastrointestinal
4.4.1 Market size and forecast 2019-2029
4.5 Dermatological
4.5.1 Minor Cuts and Wounds
4.5.2 Acne
4.5.3 Rashes, Itchy Skin, and Dermatitis/Eczema
4.5.4 Cold Sores
4.5.5 Warts
4.5.6 Fungal Skin Infections
4.5.7 Haemorrhoids
4.5.8 Other Dermatological Products
4.5.9 Market size and forecast 2018-2029
4.6 Eye Care
4.6.1 Dry Eye Syndrome
4.6.2 Bacterial Conjunctivitis
4.6.3 Ocular Allergy and Allergic Conjunctivitis
4.6.4 Treatment of Ocular Allergy/ Allergic Conjunctivitis
4.6.5 Market size and forecast 2019-2029
4.7 Smoking Cessation Aids
4.7.1 Market size and forecast 2019-2029
4.8 Other Products
4.8.1 Market size and forecast 2019-2029

5. Global OTC Pharmaceutical Market by National Market: Market Forecast 2019 – 2029
5.1 Global OTC Pharmaceuticals Market: Regional Forecast, 2019-2029
5.2 North American OTC Pharmaceuticals Market Forecasts 2019-2029
5.2.1 North American OTC Pharmaceuticals Market Forecasts by Country 2019-2029
5.2.2 USA OTC Pharmaceuticals Market Forecasts 2019-2029
5.2.3 Canada OTC Pharmaceuticals Market Forecasts 2019-2029
5.2.4 Mexico OTC Pharmaceuticals Market Forecasts 2019-2029
5.2.5 North American OTC Pharmaceuticals Market Forecasts by Product 2019-2029
5.3 South American OTC Pharmaceuticals Market Forecasts 2019-2029
5.3.1 South American OTC Pharmaceuticals Market Forecasts by Country 2019-2029
5.3.2 Brazil OTC Pharmaceuticals Market Forecasts 2019-2029
5.3.3 Argentina OTC Pharmaceutical Market Forecasts 2019-2029
5.3.4 Paraguay OTC Pharmaceuticals Market Forecasts 2019-2029
5.3.5 Bolivia OTC Pharmaceuticals Market Forecasts 2019-2029
5.3.6 Rest of South America OTC Pharmaceuticals Market Forecasts 2019-2029
5.3.7 South American OTC Pharmaceuticals Market Forecasts by Product 2019-2029
5.4 European OTC Pharmaceuticals Market Forecasts 2019-2029
5.4.1 Europe OTC Pharmaceuticals Market Forecasts by Country 2019-2029
5.4.2 Germany OTC Pharmaceuticals Market Forecasts 2019-2029
5.4.3 France OTC Pharmaceuticals Market Forecasts 2019-2029
5.4.4 U.K. OTC Pharmaceuticals Market Forecasts 2019-2029
5.4.5 Italy OTC Pharmaceuticals Market Forecasts 2019-2029
5.4.6 Spain OTC Pharmaceuticals Market Forecasts 2019-2029
5.4.7 Rest of Europe OTC Pharmaceuticals Market Forecasts 2019-2029
5.4.8 Europe OTC Pharmaceuticals Market Forecasts by Product 2019-2029
5.5 Asia-Pacific OTC Pharmaceuticals Market Forecasts 2019-2029
5.5.1 Asia-Pacific OTC Pharmaceuticals Market Forecasts by Country 2019-2029
5.5.2 Japan OTC Pharmaceuticals Market Forecasts 2019-2029
5.5.3 China OTC Pharmaceuticals Market Forecasts 2019-2029
5.5.4 India OTC Pharmaceuticals Market Forecasts 2019-2029
5.5.5 Australia OTC Pharmaceuticals Market Forecasts 2019-2029
5.5.6 Thailand OTC Pharmaceuticals Market Forecasts 2018-2029
5.5.7 Rest of Asia-Pacific OTC Pharmaceuticals Market Forecasts 2019-2029
5.5.8 Asia-Pacific OTC Pharmaceuticals Market Forecasts by Product 2018-2029
5.6 Rest of the World OTC Pharmaceuticals Market Forecasts 2019-2029
5.6.1 Rest of the World OTC Pharmaceuticals Market Forecasts by Country 2019-2029
5.6.2 Middle East OTC Pharmaceuticals Market Forecasts 2019-2029
5.6.3 Africa OTC Pharmaceuticals Market Forecasts 2019-2029
5.6.4 Other Countries OTC Pharmaceuticals Market Forecasts 2019-2029
5.6.5 Rest of the World OTC Pharmaceuticals Market Forecasts by Product 2019-2029

6. Qualitative Analysis of the OTC Pharmaceuticals Market
6.1 SWOT Analysis of the OTC Pharmaceuticals Market
6.2 Strengths
6.2.1 Healthcare Systems, Third Party Payers, and Manufacturers: All have Incentives to Push for OTC Drug Consumption
6.3 Weaknesses
6.3.1 Pharma Companies Remain Focused on Prescription Drugs
6.3.2 Manufacturing Problems Affects Sales and Reputation of OTC Drugs
6.3.3 OTC Products are Vulnerable to Price Controls by Governments
6.3.4 Downward Cost Pressures of OTC Drugs
6.4 Opportunities
6.4.1 Demographic and Economic Changes Will Create Growth Opportunities
6.4.2 New OTC Switch Categories
6.4.3 Strong Growth in Emerging Markets
6.4.4 New Healthcare Technologies May enable OTC Approvals
6.4.5 Opportunities to Drive Sales via Social Media and Online Marketing
6.4.6 Self-Medication can Reduce the Under Treatment of Disease
6.5 Threats
6.5.1 Competition from Private-Label Brands Will Reduce Profitability
6.5.2 Regulatory Concerns Over Safety and Misuse may Lead to Withdrawal of Products
6.5.3 Resistance to OTC Switching from Some Groups in Certain Countries
6.6 Porter’s Five Forces Analysis of the OTC Pharmaceuticals Market
6.7 Rivalry Among Competitors [High]
6.8 Threat of New Entrants [Medium]
6.9 Power of Suppliers [Low]
6.10 Power of Buyers [Medium]
6.11 Threats of Substitutes [Medium]

7. Leading Companies in the OTC Pharmaceuticals Market
7.1 Bayer AG
7.1.1 Bayer AG: Company Overview
7.1.2 Bayer AG: Financial Highlights
7.1.3 Bayer AG: Product Portfolio
7.1.4 Bayer AG: Recent Developments
7.2 GlaxoSmithKline PLC (GSK Consumer Care)
7.2.1 GlaxoSmithKline PLC: Company Overview
7.2.2 GlaxoSmithKline PLC: Financial Highlights
7.2.3 GlaxoSmithKline PLC: Product Portfolio
7.2.4 GlaxoSmithKline PLC: Recent Developments
7.3 Johnson & Johnson
7.3.1 Johnson & Johnson: Company Overview
7.3.2 Johnson & Johnson: Financial Highlights
7.3.3 Johnson & Johnson: Product Portfolio
7.3.4 Johnson & Johnson: Recent Developments
7.4 Perrigo Company PLC
7.4.1 Perrigo Company PLC: Company Overview
7.4.2 Perrigo Company PLC: Financial Highlights
7.4.3 Perrigo Company PLC: Product Portfolio
7.4.4 Perrigo Company PLC: Recent Developments
7.5 Daiichi Sankyo Company, Limited
7.5.1 Daiichi Sankyo Company, Limited: Company Overview
7.5.2 Daiichi Sankyo Company, Limited: Financial Highlights
7.5.3 Daiichi Sankyo Company Limited: Recent Developments
7.6 Pfizer Inc.
7.6.1 Pfizer Inc.: Company Overview
7.6.2 Pfizer Inc.: Financial Highlights
7.6.3 Pfizer Inc.: Product Portfolio
7.6.4 Pfizer Inc.: Recent Developments
7.7 The Procter & Gamble Company
7.7.1 The Procter & Gamble Company: Company Overview
7.7.2 The Procter & Gamble Company: Financial Highlights
7.7.3 The Procter & Gamble Company: Product Portfolio
7.7.4 The Procter & Gamble Company: Recent Developments
7.8 Sanofi S.A.
7.8.1 Sanofi S.A.: Company Overview
7.8.2 Sanofi S.A.: Financial Highlights
7.8.3 Sanofi S.A.: Product Portfolio
7.8.4 Sanofi S.A: Recent Developments
7.9 Reckitt Benckiser Group PLC
7.9.1 Reckitt Benckiser Group PLC: Company Overview
7.9.2 Reckitt Benckiser Group PLC: Financial Highlights
7.9.3 Reckitt Benckiser Group PLC: Product Portfolio
7.9.4 Reckitt Benckiser Group PLC: Recent Developments
7.10 Cipla, Inc.
7.10.1 Cipla Inc.: Company Overview
7.10.2 Cipla Inc.: Financial Highlights
7.10.3 Cipla Inc.: Product Portfolio
7.10.4 Cipla Inc.: Recent Developments
7.11 AstraZeneca plc
7.11.1 AstraZeneca plc: Company Overview
7.11.2 AstraZeneca plc: Financial Highlights
7.11.3 AstraZeneca plc: Product Portfolio
7.12 Bristol Myers Squibb
7.12.1 Bristol Myers Squibb: Company Overview
7.12.2 Bristol Myers Squibb: Financial Highlights
7.12.3 Bristol Myers Squibb: Product Portfolio
7.13 Dr. Reddy’s Laboratories Limited
7.13.1 Dr. Reddy’s Laboratories Limited: Company Overview
7.13.2 Dr. Reddy’s Laboratories Limited: Financial Highlights
7.13.3 Dr. Reddy’s Laboratories Limited: Product Portfolio
7.13.4 Dr. Reddy’s Laboratories Limited: Recent Developments
7.14 Eisai Co., Ltd.
7.14.1 Eisai Co., Ltd.: Company Overview
7.14.2 Eisai Co., Ltd.: Financial Highlights
7.14.3 Eisai Co., Ltd.: Product Portfolio
7.15 Mylan N.V.
7.15.1 Mylan N.V.: Company Overview
7.15.2 Mylan N.V.: Financial Highlights
7.15.3 Mylan N.V.: Product Portfolio
7.15.4 Mylan N.V.: Recent Developments
7.16 List of Key Players in global OTC Market

8. Conclusions
8.1 The World OTC Pharmaceuticals Market in 2018-2029
8.1.1 The Leading OTC Product Categories
8.1.2 Leading National Markets: Emerging Market Represent a Large Proportion
8.2 The Global OTC Pharmaceuticals Market Growth Factors
8.2.1 Potential OTC Switching, 2018-2029
8.2.2 Emerging OTC Markets
8.3 Concluding Remarks

Appendices
Associated Visiongain Reports
Visiongain Report Sales Order Form
About Visiongain
Visiongain report evaluation form

List of Table
Table 3.1 Global OTC Pharmaceutical Market Forecast ($bn, AGR%, CAGR%) 2019-2029
Table 4.1 Global OTC Pharmaceuticals Market Forecast by Product ($bn, AGR%, CAGR%) 2019-2029
Table 4.2 OTC Cough, Cold and Allergy Active Ingredients, 2018
Table 4.3 Global OTC Pharmaceuticals Market for Cough, Cold and Allergy Market Forecast, ($bn, AGR%, CAGR%) 2019-2029
Table 4.4 Global OTC Pharmaceuticals Market for Cough, Cold and Allergy Market Forecast by Geography ($bn, AGR%, CAGR%) 2019-2029
Table 4.5 OTC Internal Analgesic Active Ingredients, 2018
Table 4.6 OTC External Analgesic Active Ingredients, 2018
Table 4.7 Global OTC Pharmaceuticals Market for Analgesics Market Forecast, ($bn, AGR%, CAGR%) 2019-2029
Table 4.8 Global OTC Pharmaceuticals Market for Analgesics Market Forecast by Geography ($bn, AGR%, CAGR%) 2019-2029
Table 4.9 Global OTC Pharmaceuticals Market for Gastrointestinal Market Forecast, ($bn, AGR%, CAGR%) 2019-2029
Table 4.10 Global OTC Pharmaceuticals Market for Gastrointestinal Market Forecast by Geography ($bn, AGR%, CAGR%) 2019-2029
Table 4.11 OTC Antifungal Active Ingredients, 2018
Table 4.12 Global OTC Pharmaceuticals Market for Dermatological Market Forecast, ($bn, AGR%, CAGR%) 2019-2029
Table 4.13 Global OTC Pharmaceutical Market for Dermatological Market Forecast by Geography, ($bn, AGR%, CAGR%) 2019-2029
Table 4.14 OTC Dry Eye Syndrome Active Ingredients, 2018
Table 4.15 OTC Bacterial Conjunctivitis Active Ingredients, 2018
Table 4.16 OTC Ocular Allergy Active Ingredients, 2018
Table 4.17 Global OTC Pharmaceutical Market for Eye Care Market Forecast, ($bn, AGR%, CAGR%) 2019-2029
Table 4.18 Global OTC Pharmaceutical Market for Eye Care Market Forecast by Geography ($bn, AGR%, CAGR%) 2019-2029
Table 4.19 OTC Smoking Cessation Aid Active Ingredients, 2018
Table 4.20 Global OTC Pharmaceuticals Market for Smoking Cessation Aids Market Forecast, ($bn, AGR%, CAGR%) 2019-2029
Table 4.21 Global OTC Pharmaceuticals Market for Smoking Cessation Aids Market Forecast by Geography ($bn, AGR%, CAGR%) 2019-2029
Table 4.22 Global OTC Pharmaceuticals Market for Other Products Market Forecast, ($bn, AGR%, CAGR%) 2019-2029
Table 4.23 Global OTC Pharmaceuticals Market for Other Products Market Forecast by Geography ($bn, AGR%, CAGR%) 2019-2029
Table 5.1 Global OTC Pharmaceuticals Market Forecast by Geography ($bn, AGR%, CAGR%) 2019-2029
Table 5.2 North America OTC Pharmaceutical Market Forecast by Country ($bn, AGR%, CAGR%) 2019-2029
Table 5.3 USA OTC Pharmaceuticals Market Forecast ($bn, AGR%, CAGR%) 2019-2029
Table 5.4 Canada OTC Pharmaceutical Market Forecast, ($bn, AGR%, CAGR%) 2019-2029
Table 5.5 Mexico OTC Pharmaceutical Market Forecast, ($bn, AGR%, CAGR%) 2019-2029
Table 5.6 North America OTC Pharmaceuticals Market Forecast by Product ($bn, AGR%, CAGR%) 2019-2029
Table 5.7 South America OTC Pharmaceuticals Market Forecast by Country ($bn, AGR%, CAGR%) 2019-2029
Table 5.8 Brazil OTC Pharmaceutical Market Forecast, ($bn, AGR%, CAGR%) 2019-2029
Table 5.9 Argentina OTC Pharmaceutical Market Forecast, ($bn, AGR%, CAGR%) 2019-2029
Table 5.10 Paraguay OTC Pharmaceutical Market Forecast, ($bn, AGR%, CAGR%) 2019-2029
Table 5.11 Bolivia OTC Pharmaceutical Market Forecast, ($bn, AGR%, CAGR%) 2019-2029
Table 5.12 Rest of South America OTC Pharmaceuticals Market Forecast, ($bn, AGR%, CAGR%) 2019-2029
Table 5.13 South America OTC Pharmaceuticals Market Forecast by Product ($bn, AGR%, CAGR%) 2019-2029
Table 5.14 European OTC Pharmaceuticals Market Forecast by Country ($bn, AGR%, CAGR%) 2019-2029
Table 5.15 Germany OTC Pharmaceuticals Market Forecast ($bn, AGR%, CAGR%) 2019-2029
Table 5.16 France OTC Pharmaceuticals Market Forecast ($bn, AGR%, CAGR%) 2019-2029
Table 5.17 U.K. OTC Pharmaceuticals Market Forecast ($bn, AGR%, CAGR%) 2019-2029
Table 5.18 Italy OTC Pharmaceuticals Market Forecast ($bn, AGR%, CAGR%) 2019-2029
Table 5.19 Spain OTC Pharmaceuticals Market Forecast ($bn, AGR%, CAGR%) 2019-2029
Table 5.20 Rest of Europe OTC Pharmaceuticals Market Forecast ($bn, AGR%, CAGR%) 2019-2029
Table 5.21 Europe OTC Pharmaceuticals Market Forecast by Product ($bn, AGR%, CAGR%) 2019-2029
Table 5.22 Asia-Pacific OTC Pharmaceuticals Market Forecast by Country ($bn, AGR%, CAGR%) 2019-2029
Table 5.23 Japan OTC Pharmaceuticals Market Forecast ($bn, AGR%, CAGR%) 2019-2029
Table 5.24 China OTC Pharmaceuticals Market Forecast ($bn, AGR%, CAGR%) 2019-2029
Table 5.25 India OTC Pharmaceuticals Market Forecast, ($bn, AGR%, CAGR%) 2019-2029
Table 5.26 Australia OTC Pharmaceuticals Market Forecast ($bn, AGR%, CAGR%) 2019-2029
Table 5.27 Thailand OTC Pharmaceuticals Market Forecast ($bn, AGR%, CAGR%) 2019-2029
Table 5.28 Rest of Asia-Pacific OTC Pharmaceuticals Market Forecast ($bn, AGR%, CAGR%) 2019-2029
Table 5.29 Asia-Pacific OTC Pharmaceuticals Market Forecast by Product ($bn, AGR%, CAGR%) 2019-2029
Table 5.30 Rest of World OTC Pharmaceuticals Market Forecast by Country ($bn, AGR%, CAGR%) 2019-2029
Table 5.31 Middle East OTC Pharmaceuticals Market Forecast, ($bn, AGR%, CAGR%) 2019-2029
Table 5.32 Africa OTC Pharmaceuticals Market Forecast ($bn, AGR%, CAGR%) 2019-2029
Table 5.33 Other Countries OTC Pharmaceuticals Market Forecast: Revenue ($bn, AGR%, CAGR%) 2019-2029
Table 5.34 Rest of the World OTC Pharmaceuticals Market Forecast by Product ($bn, AGR%, CAGR%) 2019-2029
Table 7.1 Bayer AG: Company Overview
Table 7.2 Bayer AG: Product Portfolio
Table 7.3 Bayer AG: Recent Developments
Table 7.4 GlaxoSmithKline PLC: Company Overview
Table 7.5 GlaxoSmithKline PLC: Product Portfolio
Table 7.6 GlaxoSmithKline PLC: Recent Developments
Table 7.7 Johnson & Johnson: Company Overview
Table 7.8 Johnson & Johnson: Product Portfolio
Table 7.9 Johnson & Johnson: Recent Developments
Table 7.10 Perrigo Company PLC: Company Overview
Table 7.11 Perrigo Company PLC: Product Portfolio
Table 7.12 Perrigo Company PLC: Recent Developments
Table 7.13 Daiichi Sankyo Company, Limited: Company Overview
Table 7.14 Daiichi Sankyo Company Limited: Recent Developments
Table 7.15 Pfizer Inc.: Company Overview
Table 7.16 Pfizer Inc.: Product Portfolio
Table 7.17 Pfizer Inc.: Recent Developments
Table 7.18 The Procter & Gamble Company: Company Overview
Table 7.19 The Procter & Gamble Company: Product Portfolio
Table 7.20 The Procter & Gamble Company: Recent Developments
Table 7.21 Sanofi S.A.: Company Overview
Table 7.22 Sanofi S.A.: Product Portfolio
Table 7.23 Sanofi S.A: Recent Developments
Table 7.24 Reckitt Benckiser Group PLC: Company Overview
Table 7.25 Reckitt Benckiser Group PLC: Product Portfolio
Table 7.26 Reckitt Benckiser Group PLC: Recent Developments
Table 7.27 Cipla Inc.: Company Overview
Table 7.28 Cipla Inc.: Product Portfolio
Table 7.29 Cipla Inc.: Recent Developments
Table 7.30 AstraZeneca plc: Company Overview
Table 7.31 AstraZeneca plc: Product Portfolio
Table 7.32 Bristol Myers Squibb: Company Overview
Table 7.33 Bristol Myers Squibb: Product Portfolio
Table 7.34 Dr. Reddy’s Laboratories Limited: Company Overview
Table 7.35 Dr. Reddy’s Laboratories Limited: Product Portfolio
Table 7.36 Dr. Reddy’s Laboratories Limited: Recent Developments
Table 7.37 Eisai Co., Ltd.: Company Overview
Table 7.38 Eisai Co., Ltd.: Product Portfolio
Table 7.39 Mylan N.V.: Company Overview
Table 7.40 Mylan N.V.: Product Portfolio
Table 7.41 Mylan N.V.: Recent Developments
Table 7.42 List of Key Players in Global OTC Pharmaceuticals Marke

List of Figure
Figure 2.1 The OTC Pharmaceutical Supply Chain, 2019
Figure 3.1 OTC Pharmaceuticals Market by Product: Revenue ($bn), 2019-2029
Figure 3.2 OTC Pharmaceutical Market by Geography: Revenue ($bn) 2019-2029
Figure 4.1 Global OTC Pharmaceuticals Market by Product; Market Share (%), 2018
Figure 4.2 Global OTC Pharmaceuticals Market by Product: Revenue Forecast ($bn) 2019-2029
Figure 4.3 Global OTC Pharmaceutical Market for Cough, Cold and Allergy Market Forecast by Geography: Revenue ($bn) 2019-2029
Figure 4.4 Global OTC Pharmaceuticals Market for Analgesics Market Forecast by Geography: Revenue ($bn) 2019-2029
Figure 4.5 Global OTC Pharmaceutical Market for Gastrointestinal Market Forecast by Geography: Revenue ($bn) 2019-2029
Figure 4.6 Global OTC Pharmaceuticals Market for Dermatological Market Forecast by Geography: Revenue ($bn) 2019-2029
Figure 4.7 Global OTC Pharmaceuticals Market for Eye Care Market Forecast by Geography: Revenue ($bn) 2019-2029
Figure 4.8 OTC Pharmaceutical Market for Smoking Cessation Aids Market Forecast by Geography: Revenue ($bn) 2019-2029
Figure 4.9 Global OTC Pharmaceuticals Market for Other Products Market Forecast by Geography: Revenue ($bn) 2019-2029
Figure 5.1 Global OTC Pharmaceuticals Market Forecast by Geography: Revenue ($bn) 2019-2029
Figure 5.2 Global OTC Pharmaceuticals Market by Geography: Market Share (%), 2018
Figure 5.3 North America OTC Pharmaceuticals Market Forecast by Country: Revenue ($bn) 2019-2029
Figure 5.4 North America OTC Pharmaceuticals Market by Country: Market Share (%), 2018
Figure 5.5 USA OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029
Figure 5.6 Canada OTC Pharmaceutical Market Forecast: Revenue ($bn) 2019-2029
Figure 5.7 Mexico OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029
Figure 5.8 North America OTC Pharmaceutical Market Forecast by Product: Revenue ($bn) 2019-2029
Figure 5.9 North America OTC Pharmaceutical Market by Product: Market Share (%), 2018
Figure 5.10 South America OTC Pharmaceutical Market Forecast by Country ($bn) 2019-2029
Figure 5.11 South America OTC Pharmaceuticals Market by Country: Market Share (%), 2018
Figure 5.12 Brazil OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029
Figure 5.13 Argentina OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029
Figure 5.14 Paraguay OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029
Figure 5.15 Bolivia OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029
Figure 5.16 Rest of South America OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029
Figure 5.17 South America OTC Pharmaceuticals Market Forecast by Product: Revenue ($bn) 2019-2029
Figure 5.18 South America OTC Pharmaceuticals Market by Product: Market Share (%), 2018
Figure 5.19 Europe OTC Pharmaceuticals Market Forecast by Country ($bn) 2019-2029
Figure 5.20 Europe OTC Pharmaceutical Market by Country: Market Share (%), 2018
Figure 5.21 Germany OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029
Figure 5.22 France OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029
Figure 5.23 U.K. OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029
Figure 5.24 Italy OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029
Figure 5.25 Spain OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029
Figure 5.26 Rest of Europe OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029
Figure 5.27 Europe OTC Pharmaceuticals Market Forecast by Product: Revenue ($bn) 2019-2029
Figure 5.28 Europe OTC Pharmaceuticals Market by Product: Market Share (%), 2018
Figure 5.29 Asia-Pacific OTC Pharmaceuticals Market Forecast by Country: Revenue ($bn) 2019-2029
Figure 5.30 Asia-Pacific OTC Pharmaceutical Market by Country: Market Share (%), 2018
Figure 5.31 Japan OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029
Figure 5.32 China OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029
Figure 5.33 India OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029
Figure 5.34 Australia OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029
Figure 5.35 Thailand OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029
Figure 5.36 Rest of Asia-Pacific OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029
Figure 5.37 Asia-Pacific OTC Pharmaceuticals Market Forecast by Product: Revenue ($bn) 2019-2029
Figure 5.38 Asia-Pacific OTC Pharmaceutical Market by Product: Market Share (%), 2018
Figure 5.39 Rest of the World OTC Pharmaceuticals Market Forecast by Country: Revenue ($bn) 2019-2029
Figure 5.40 Rest of the World OTC Pharmaceuticals Market by Country: Market Share (%), 2018
Figure 5.41 Middle East OTC Pharmaceuticals Market Forecast ($bn) 2019-2029
Figure 5.42 Africa OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029
Figure 5.43 Other Countries OTC Pharmaceuticals Market Forecast: Revenue ($bn) 2019-2029
Figure 5.44 Rest of the World OTC Pharmaceuticals Market Forecast by Product: Revenue ($bn) 2019-2029
Figure 5.45 Rest of the World OTC Pharmaceuticals Market by Product, Market Share (%), 2018
Figure 6.1 Porter’s Five Analysis of the OTC Pharmaceuticals Market, 2018
Figure 7.1 Bayer AG: Revenue ($million), 2014-2018
Figure 7.2 Bayer AG: Product Segments Share (%), 2018
Figure 7.3 Bayer AG: Geographic Presence Share (%), 2018
Figure 7.4 GlaxoSmithKline PLC: Revenue ($million), 2014-2018
Figure 7.5 GlaxoSmithKline PLC: Product Segments Share (%), 2018
Figure 7.6 GlaxoSmithKline PLC: Geographical Presence Share (%), 2018
Figure 7.7 Johnson & Johnson: Revenue ($million), 2014-2018
Figure 7.8 Johnson & Johnson: Product Segments Share (%), 2018
Figure 7.9 Johnson & Johnson: Geographical Presence Share (%), 2018
Figure 7.10 Perrigo Company PLC, Revenue, ($million), 2014-2018
Figure 7.11 Perrigo Company PLC: Product Segments Share (%), 2018
Figure 7.12 Perrigo Company PLC: Geographical Presence Share (%), 2018
Figure 7.13 Daiichi Sankyo Company Limited: Revenue ($million), 2014-2018
Figure 7.14 Daiichi Sankyo Company Limited: Geographical Presence Share (%), 2018
Figure 7.15 Pfizer Inc.: Revenue ($million), 2014-2018
Figure 7.16 Pfizer Inc.: Product Segments Share (%), 2018
Figure 7.17 Pfizer Inc.: Geographical Presence Share (%), 2018
Figure 7.18 The Procter & Gamble Company: Revenue ($million), 2014-2018
Figure 7.19 The Procter & Gamble Company: Product Segments Share (%), 2018
Figure 7.20 The Procter & Gamble Company: Geographical Presence Share (%), 2018
Figure 7.21 Sanofi S.A.: Revenue ($million), 2014-2018
Figure 7.22 Sanofi S.A.: Product Segments Share (%), 2018
Figure 7.23 Sanofi S.A.: Geographical Presence Share (%), 2018
Figure 7.24 Reckitt Benckiser Group PLC: Revenue ($million), 2014-2018
Figure 7.25 Reckitt Benckiser Group PLC: Product Segments Share (%), 2018
Figure 7.26 Reckitt Benckiser Group PLC: Geographical Presence Share (%), 2018
Figure 7.27 Cipla Inc.: Revenue: ($million), 2014-2018
Figure 7.28 Cipla Inc.: Product Segments Share (%), 2018
Figure 7.29 AstraZeneca plc: Revenue ($million), 2014-2018
Figure 7.30 AstraZeneca plc: Product Segments Share (%), 2018
Figure 7.31 AstraZeneca plc: Geographical Presence Share (%), 2018
Figure 7.32 Bristol Myers Squibb: Revenue ($million), 2014-2018
Figure 7.33 Bristol Myers Squibb: Product Segments Share (%), 2018
Figure 7.34 Bristol Myers Squibb: Geographical Presence Share (%), 2018
Figure 7.35 Dr. Reddy’s Laboratories Limited: Revenue ($million), 2014-2018
Figure 7.36 Dr. Reddy’s Laboratories Limited: Product Segments Share (%), 2018
Figure 7.37 Dr. Reddy’s Laboratories Limited: Geographical Presence Share (%), 2018
Figure 7.38 Eisai Co., Ltd.: Revenue ($million), 2014-2018
Figure 7.39 Eisai Co., Ltd.: Product Segments Share (%), 2018
Figure 7.40 Eisai Co., Ltd.: Geographical Presence Share (%), 2018
Figure 7.41 Mylan N.V.: Revenue ($million), 2014-2018
Figure 7.42 Mylan N.V.: Product Segments Share (%), 2018
Figure 7.43 Mylan N.V.: Geographical Presence Share (%), 2018
Figure 8.1 Global OTC Pharmaceuticals Market Revenue, by Product Type ($bn), 2019-2029
Figure 8.2 Global OTC Pharmaceuticals Market: Revenue by Geography ($bn), 2019-2029



★調査レポート[OTC医薬品の世界市場2019-2029] ( Global OTC Pharmaceutical Market Forecast 2019-2029 / VGN910368) 販売に関する免責事項
[OTC医薬品の世界市場2019-2029] ( Global OTC Pharmaceutical Market Forecast 2019-2029 / VGN910368) についてEメールでお問い合わせ


◆H&Iグローバルリサーチ株式会社のお客様(例)◆